Monali Praharaj

Title: Monali Praharaj: Innovator in Cancer Therapeutics

Introduction

Monali Praharaj is a distinguished inventor based in Baltimore, MD (US). She has made significant contributions to the field of cancer therapeutics, focusing on innovative methods to enhance the immune response against tumors. Her work is pivotal in developing new strategies for cancer treatment.

Latest Patents

Monali holds 1 patent for her groundbreaking invention titled "Recombinant therapeutic interventions for cancer." This patent describes methods for suppressing the expression of myeloid-derived suppressor cells (MDSCs), M2 macrophages, and Treg cells in tumors. Additionally, it outlines how to induce the expression of macrophages, dendritic cells (DCs), and T effector cells in a tumor in a subject. The invention includes a pharmaceutical composition comprising a strain of an expression vector that is administered to a subject, showcasing her innovative approach to cancer treatment.

Career Highlights

Monali Praharaj is affiliated with The Johns Hopkins University, where she continues her research and development in cancer therapeutics. Her work is characterized by a commitment to advancing medical science and improving patient outcomes through innovative solutions.

Collaborations

Monali collaborates with esteemed colleagues, including William R Bishai and Trinity J Bivalacqua. These partnerships enhance her research efforts and contribute to the advancement of cancer therapies.

Conclusion

Monali Praharaj is a remarkable inventor whose work in cancer therapeutics is making a significant impact in the medical field. Her innovative approaches and collaborations are paving the way for new treatment options for cancer patients.